А А Карлсен
Biographic Data
| ID | 7712114 |
|---|---|
| NAME | А А Карлсен |
| GIVEN NAMES | А А |
| FAMILY NAME | Карлсен |
| SIGNATURE | КАРЛСЕН А А |
| AFFILIATIONS | Russian Medical Academy of Continuous Professional Education |
| ORCID | 0000-0002-6013-7768 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation
Background: To combat the hesitancy towards implementing a hepatitis A universal mass vaccination (UMV) strategy and to provide healthcare authorities with a comprehensive analysis of the potential outcomes and benefits of the implementation of such a vaccination program, we projected HAV seroprevalence and incidence rates in the total population of the Russian Federation and estimated the pediatric vaccination threshold required to achieve an in…
Community screening for hepatitis C virus infection in a low-prevalence population
Overall HCV prevalence is low, except in people 60 years or older. The latter should be considered as a target group for HCV screening. The high agreement between HCV RNA and HCV Ag suggests the utility of HCV Ag testing to confirm active infection in screening programs
No prominent works on this page.
Community screening for hepatitis C virus infection in a low-prevalence population
Overall HCV prevalence is low, except in people 60 years or older. The latter should be considered as a target group for HCV screening. The high agreement between HCV RNA and HCV Ag suggests the utility of HCV Ag testing to confirm active infection in screening programs
Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation
Background: To combat the hesitancy towards implementing a hepatitis A universal mass vaccination (UMV) strategy and to provide healthcare authorities with a comprehensive analysis of the potential outcomes and benefits of the implementation of such a vaccination program, we projected HAV seroprevalence and incidence rates in the total population of the Russian Federation and estimated the pediatric vaccination threshold required to achieve an in…
Environmental health (2 works) · Epidemiology (2 works) · Medicine (2 works) · Population (2 works) · Biostatistics (1 work) · Demography (1 work) · Geography (1 work) · Hepatitis (1 work) · Hepatitis A (1 work) · Hepatitis a virus (1 work)